| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/17/2006 | US20060182721 Method of preparing langerhans cell from cd14-positive cell being human peripheral blood mononuclear cell with use of notch ligand delta-1, gm-csf and tgf-ss |
| 08/17/2006 | US20060182720 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182712 CCR ligands for stem cell homing |
| 08/17/2006 | CA2597431A1 A method of producing an analgesic composition from plasma or serum and use in treating pain |
| 08/17/2006 | CA2597229A1 Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic |
| 08/16/2006 | EP1690936A1 Method of enhancing hematopoiesis-supporting ability of immortalized human bone marrow stroma cell by transferring indian hedgehog gene |
| 08/16/2006 | EP1690929A1 Regeneration treatment system |
| 08/16/2006 | EP1690927A1 Natural killer cell lines and methods of use |
| 08/16/2006 | EP1690546A2 Transplants for myocardial scars and method and cellular preparations therefor |
| 08/16/2006 | EP1690545A2 A combination therapy for HIV infections |
| 08/16/2006 | EP1689855A1 Tangential flow filtration devices and methods for stem cell enrichment |
| 08/16/2006 | EP1689854A2 Placental stem cells and uses thereof |
| 08/16/2006 | EP1689774A1 Sperm protective polypeptides and uses thereof |
| 08/16/2006 | EP1689431A1 Cytoprotective effects of ethyl pyruvate |
| 08/16/2006 | EP1689423A2 Regulation of sperm function |
| 08/16/2006 | EP1689418A1 Use of strain of bacillus and byproducts thereof for inhibiting formation of blood vessels |
| 08/16/2006 | EP1689417A2 Moderating the effect of endotoxins |
| 08/16/2006 | EP1689359A2 Composition for the treatment of arthrosis/arthritis, especially for treating joints |
| 08/16/2006 | EP1689348A2 Oligosaccharide compositions and use thereof in the treatment of infection |
| 08/16/2006 | EP1689321A2 Artificial tissue systems and uses thereof |
| 08/16/2006 | EP1626729A4 Compositions and methods for symptomatic relief |
| 08/16/2006 | EP1450832B1 Lactic acid bacteria and their use for treating and preventing cancer |
| 08/16/2006 | EP1370641B1 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1220908B1 Isolated peptides which bind to mhc class ii molecules, and uses thereof |
| 08/16/2006 | EP1032651B1 INDUCIBLE CELLULAR IMMUNITY THROUGH ACTIVATION OF Th1 AND SUPPRESSION OF Th2 RESPONSES BY MACROPHAGES |
| 08/16/2006 | EP0972519B1 Immune tolerance inducers |
| 08/16/2006 | EP0836484B1 In vitro packaging of adeno-associated virus dna |
| 08/16/2006 | EP0784690B1 Complementary adenoviral vector systems and cell lines |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820018A Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 08/16/2006 | CN1819838A Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells |
| 08/16/2006 | CN1819771A A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal |
| 08/16/2006 | CN1818058A In vitro cell culturing method |
| 08/16/2006 | CN1817381A Pillow with medicine for balancing cervical vertebra |
| 08/16/2006 | CN1817367A Activation and inhibition of the immune system |
| 08/16/2006 | CN1817366A Medicinal composition for treating rheumatosis and preparation thereof |
| 08/16/2006 | CN1817364A Medicine for cancer treatment |
| 08/16/2006 | CN1817361A Medicine for treating psoriasis |
| 08/16/2006 | CN1817358A Zhi Tengling by osmation |
| 08/16/2006 | CN1817350A Silkworm sand total alkaloid and preparation thereof |
| 08/16/2006 | CN1817157A Preparation of kidney-tonifying and fatigue-dispelling bean milk with micro-meter Hairy Antler safflower |
| 08/16/2006 | CN1817156A Preparation of kidney-tonifying and fatigue-dispelling bean-milk tablet with micro-meter Hairy Antler safflower |
| 08/16/2006 | CN1817155A Preparation of digestive and Yiwei milk tablet with micro-meter Huaguoshan golden monkey sugar |
| 08/16/2006 | CN1817154A Preparation of digestive and Yiwei bean-milk powder with micro-meter Huaguoshan golden monkey sugar |
| 08/16/2006 | CN1817153A Preparation of digestive and Yiwei milk powder with micro-meter Huaguoshan and golden monkey sugar |
| 08/16/2006 | CN1817152A Preparation digestive and Yiwei bean milk powder with micro-meter Huaguoshan sugar and golden monkey |
| 08/16/2006 | CN1269960C Human FGF23 protein mutant lowering blood phosphorus level |
| 08/16/2006 | CN1269955C Manufacture of hemoglobin-based oxygen carrier |
| 08/16/2006 | CN1269940C Method for extracting lipid from marine and aquatic animal tissues |
| 08/16/2006 | CN1269534C Chondric implant and production method thereof |
| 08/16/2006 | CN1269520C Medicine for treating human lithic disease |
| 08/16/2006 | CN1269515C A pharmaceutical composition for treating hypertension, externally applied paste and preparation method thereof |
| 08/16/2006 | CN1269514C Kidney supplementing life prolonging preparation and its making method |
| 08/16/2006 | CN1269510C Medicine for treating wound |
| 08/16/2006 | CN1269490C Composition of suppressing infection, and veberage and food contg. same |
| 08/16/2006 | CN1269489C Medicines for relieving intestinal disorders |
| 08/16/2006 | CN1269488C Pharmaceutical composition capable of resisting cancer and easing pain |
| 08/16/2006 | CN1269485C Compound comprised royal jelly and lecithin and nutrient composition comprising said compound |
| 08/15/2006 | US7091040 P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7090875 Bean extract; fermentation |
| 08/15/2006 | US7090856 Anti-fouling exopolysaccharides isolated from cultures of Vibrio alginolyticus and Vibrio proteolyticus |
| 08/15/2006 | US7090840 Lactobacillus paracasei subsp. paracasei strain antibacterial against Helicobacter pylori and Escherichia coli 0157:h7 |
| 08/15/2006 | US7090839 Method of treatment of human immunodeficiency diseases |
| 08/10/2006 | WO2006084284A2 Adipose derived adult stromal cells exhibiting characteristics of endothelial cells |
| 08/10/2006 | WO2006084095A1 Compositions and methods for less immunogenic protein formulations |
| 08/10/2006 | WO2006084040A2 Engineering vascularized muscle tissue |
| 08/10/2006 | WO2006083795A1 Method for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia |
| 08/10/2006 | WO2006083455A1 Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditions |
| 08/10/2006 | WO2006083355A2 Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics |
| 08/10/2006 | WO2006081808A1 Pharmaceutical substance for the treatment of multiple sclerosis and aids |
| 08/10/2006 | WO2006081741A1 Quinazoline compounds or their medical salts and preparation and medical usage thereof |
| 08/10/2006 | WO2006081620A1 Cd4+ cd25+ t-cells activated to a specific antigen |
| 08/10/2006 | WO2006050270A3 Compositions and methods for treating hyperproliferative disorders |
| 08/10/2006 | WO2005113749A3 Stem cell populations and methods of use |
| 08/10/2006 | WO2004060381A8 Rabbit skin comprising biological active substance and its use |
| 08/10/2006 | WO2003065999A3 Proliferated cell lines and uses thereof |
| 08/10/2006 | WO2003017920A3 Protective factors against inflammation, burns and noxious stimuli |
| 08/10/2006 | WO2003000852A3 Method of producing region-specific neurons from human neuronal stem cells |
| 08/10/2006 | US20060179493 Transgenically produced non-secreted proteins |
| 08/10/2006 | US20060177928 Method of generating neural stem cells |
| 08/10/2006 | US20060177927 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering |
| 08/10/2006 | US20060177925 Kidney derived stem cells and methods for their isolation, differentiation and use |
| 08/10/2006 | US20060177909 Preparation of immunoglobulin |
| 08/10/2006 | US20060177901 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 08/10/2006 | US20060177819 genetic engineered polynucleotides comprising nucleotide sequences that code alphavirus replication recognition sequences, nonstructural proteins and heterologous polynucleotides; infectious, replication-defective alphavirus particles used for immunotherapy, treatment of cancer and gene delivery |
| 08/10/2006 | US20060177810 Method of inhibiting freeze concentrating of substance in wet material, method of inhibiting deactivation of physiologically active substance, and process for producing lyophilizate or frozen matter having component homogeneously diffused therein |
| 08/10/2006 | US20060177526 Pharmaceutical preparation |
| 08/10/2006 | US20060177516 Food-supplement composition suitable for promoting iron absorption |
| 08/10/2006 | US20060177515 Method of producing autogenous or allogenic blood serum and related logistics |
| 08/10/2006 | US20060177514 Preparation of a therapeutic composition |
| 08/10/2006 | US20060177459 Treatment and diagnosis of infertitlity using TGFbeta or activin |
| 08/10/2006 | US20060177433 Treatment of alpha-galactosidase a deficiency |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | US20060177429 applying to skin or mucous membrane of a mammal a composition comprising an extracellular product of a Pseudomonas lindbergii strain, an extracellular product of a Bacillus coagulans strain, and an anti-fungal agent selected from Amphotericin B, Carbol-Fuchsin, Ciclopirox, for example |
| 08/10/2006 | US20060177427 DNA coding for endo-beta-galactosidase |
| 08/10/2006 | US20060177426 Method of preserving lyophilized microorganisms for transport, storage and recovery of viable microorganisms |
| 08/10/2006 | US20060177424 Administering a fungicide including Bacillus subtilis, Lactobacillus sporogenes, and Streptococcus faecalis; paarticularly when the disease state is autism, colitis or Crohn's Disease; including a carrier such as fructooligosaccharides; dosage; nutrients; food additives |